Researchers have discovered that Daphne pseudomezereum (commonly known as Onishibari) contains a substance inhibiting ...

The U.S. recently backed out of the United Nation's HIV/AIDS program and froze billions in foreign HIV-prevention efforts.

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

The House of Representatives narrowly passed a budget resolution, which Malliotakis voted in favor of, late last month.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The significant health progress made over the past decade in Central, Eastern, Southern and West Africa—where many countries ...

The national health department has tried to reassure the public that the country’s HIV response is mostly funded by the ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

In his Tuesday address to Congress, President Trump listed U.S.-funded programs that he considers an "appalling waste" — ...

Since 1993, groundbreaking HIV science has been presented here ... Beyrer's felt the impact of funding cuts first-hand. His partner worked for an organisation funded by Pepfar, the US ...